These results are consistent with the RT-PCR results in our patient cohort with the SEER breast cancer patients that higher RAD52 mRNA expression was associated with poor patient outcomes in those who received surgery only, radiation, or surgery and radiation (Figure S8, Supplementary File S1). Here, RAD52 is linked to breast carcinoma.